News

2014

New scanner could eliminate unnecessary biopsies for women…. News from Canada

August 19, 2014 – Guided Therapeutics Initiates Cervical Cancer Screening Trial for LuViva® Advanced Cervical Scan

July 25, 2014 – Guided Therapeutics Files PMA Amendment with FDA for LuViva® Advanced Cervical Scan

July 17, 2014 – Guided Therapeutics Granted Additional Key Patent for LuViva® Advanced Cervical Scan

July 10, 2014 – Guided Therapeutics’ LuViva® Advanced Cervical Scan Awarded Mexican Regulatory Approval

July 2, 2014 – Guided Therapeutics Second Quarter Sales to Reach $200,000; Update Timing for Amended PMA Application for LuViva® Advanced Cervical Scan

June 12, 2014 – Guided Therapeutics’ LuViva® Advanced Cervical Scan Wins Prestigious Medical Design Award

May 27, 2014 – Guided Therapeutics’ LuViva® Advanced Cervical Scan Detected 100% of Precancers in New Blinded Clinical Study Presented at an International Cervical Pathology and Colposcopy Conference

May 14, 2014 – Guided Therapeutics Set to File Amended PMA Application for LuViva® Advanced Cervical Scan After “Productive” Face-to-Face Meeting with FDA

April 10, 2014 – Guided Therapeutics Receives May 8th Meeting Date from FDA to Discuss LuViva® Advanced Cervical Scan PMA Application

April 9, 2014 – Guided Therapeutics’ LuViva® Honored as Finalist in the Medical Device Excellence Awards

March 27, 2014 – Guided Therapeutics Submits Request for Face to Face Meeting with FDA; Receives Notification on PMA Extension for LuViva® Advanced Cervical Scan

March 18, 2014 – HPV Screening Beneficial for Guided Therapeutics’ LuViva® Advanced Cervical Scan in Developed Countries; No Anticipated Impact in Developing Countries

February 18, 2014 – New Clinical Study Results of Guided Therapeutics’ LuViva® Advanced Cervical Scan to be Presented by Key Opinion Leaders at Top International Medical Conference

 

2013

October 10, 2013 – Guided Therapeutics Secures Additional Distribution for LuViva® Advanced Cervical Scan

September 9, 2013 – Guided Therapeutics Receives Additional Questions from FDA for LuViva® Advanced Cervical Scan

July 3, 2013 – Guided Therapeutics Continues to Await Update from FDA on Its PMA Application for LuViva® Advanced Cervical Scan

July 2, 2013 – Guided Therapeutics and I.T.E.M. Medical Technologies Group Announce Turkish Ministry of Health Sponsored Cervical Cancer Prevention Program Involving the LuViva® Advanced Cervical Scan

June 5, 2013 – Guided Therapeutics’ LuViva® Advanced Cervical Scan Cited as Promising Solution to Reduce Unnecessary, Painful and Costly Procedures in European Healthcare Settings

May 1, 2013 – Guided Therapeutics’ LuViva® Advanced Cervical Scan Clinical Trial Results to be Published in Journal, Gynecologic Oncology

April 17, 2013 – Guided Therapeutics Ships Initial Edition 3 CE Marked LuViva® Advanced Cervical Scan

February 14, 2013 – Guided Therapeutics Passes Annual ISO Quality Audit Necessary for Continued CE Mark Certification

January 18, 2013 – Guided Therapeutics to Showcase LuViva® Advanced Cervical Scan at Arab Health 2013

January 7, 2013 – Guided Therapeutics Successfully Completes Canadian Standard Association Requirements for LuViva® Advanced Cervical Scan

 

2012

December 5, 2012 – Guided Therapeutics Successfully Completes Electrical Testing of LuViva® Advanced Cervical Scan for Edition 3 CE and Canadian Standards Association Marks

November 13, 2012 – Guided Therapeutics Submits PMA Amendment to FDA for LuViva® Advanced Cervical Scan